GlassScriptPhysician profile
Ann M Harp
NPI 1265910749
$1,569.31
in general payments reported to CMS, 2019-2025
21 companies · $492 in 2025
The $492 reported for 2025 was more than what a typical Adult Health (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $186).
See the full distribution for Adult Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $210 · 2022: $205 · 2023: $379 · 2024: $283 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,154.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $259.82 | 2023-2025 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $207.91 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $181.94 | 2021-2025 | Prolaris |
| Janssen Biotech, INC. | $130.20 | 2023-2025 | Erleada, Akeega |
| Abbvie INC. | $123.65 | 2022-2025 | |
| Rochester Medical Corporation | $102.28 | 2021-2022 | |
| Urogen Pharma, INC. | $90.99 | 2021 | |
| Endo Pharmaceuticals INC. | $63.27 | 2022-2023 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $60.30 | 2023-2025 | Gemtesa |
| Pfizer INC. | $56.43 | 2024-2025 | |
| Axonics, INC. | $46.76 | 2021-2023 | Axonics |
| Antares Pharma, INC. | $44.77 | 2024-2025 | Xyosted |
| Procept Biorobotics Corporation | $41.30 | 2024 | Aquabeam System |
| Astrazeneca Pharmaceuticals LP | $27.41 | 2021-2022 | |
| Boston Scientific Corporation | $26.47 | 2023 | Rezum Generator |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $22.81 | 2024 | Irrisept |
| Angiodynamics, INC. | $19.91 | 2025 | Nanoknife |
| Novo Nordisk INC | $17.56 | 2024 | Rivfloza |
| Urovant Sciences INC | $16.15 | 2022 | |
| Coloplast Corp | $15.74 | 2023 | Speedicath |
| Merck Sharp & Dohme LLC | $13.64 | 2024 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Harp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.